𝔖 Bobbio Scriptorium
✦   LIBER   ✦

332 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C HCV genotype 1: safety and tolerability

✍ Scribed by Charles Howell; Lennox S. Jeffers; William Cassidy; K. Rajender Reddy; Susan Sheridan; Irwin Ho; Sarkis Khouri; George Harb

Book ID
119530241
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
148 KB
Volume
38
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2a (40 kd) and ribavi
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1
✍ Lennox J. Jeffers; William Cassidy; Charles D. Howell; Sylvia Hu; K. Rajender Re 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Black Americans (blacks) have a high prevalence of chronic hepatitis C virus (HCV) infection and respond poorly to therapy with interferon alfa-based regimens, but they have been underrepresented in clinical trials. The aim of this study was to assess the rate of sustained virological response (SVR)

Peginterferon alfa-2a (40 kd) and ribavi
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1
✍ Michal R. Pijak; Frantisek Gazdik; Stefan Hrusovsky 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

An interesting report by Streetz et al. published in HEPATOLOGY described the production of hepatocyte conditional gp130 knockout mice subjected to chronic liver injury by repeated carbon tetrachloride (CCl 4 ) treatment. 1 Chronic injury induces liver regeneration by recruitment of cells from a pre